Roxadustat in CKD and transplant patients: A new era in anemia management

The aim of this study was to evaluate the efficacy and safety of Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the management of anemia in patients with chronic kidney disease (CKD), including hemodialysis-dependent (HDD), non-dialysis-dependent (NDD), and renal...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Muhammad Tassaduq Khan, Sidrah Rashid, Syed Hasan farooq, Sabahat Sarfaraz, Rashid bin Hamid, Naranjan Lal
Format:	Artigo
Sprog:	Inglês
Udgivet:	Liaquat University of Medical and Health Sciences 2025-03-01
Serier:	Liaquat Medical Research Journal
Fag:	Roxadustat, Anemia, Chronic Kidney Disease, Hemoglobin, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Safety, Efficacy, Hemodialysis, Non-Dialysis, Renal Transplant.
Online adgang:	http://121.52.154.206/index.php/LMRJ/article/view/1284
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!